Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,936 total articles
Build-A-Bear (BBW) sold off after its 08/27/2026 Q2 print — revenue missed and international franchising flagged a sharp decline — but the stock now trades at a single-digit P/E, EV/EBITDA ~4.0, and yields ~3.0%. The recent dip and technical oversold readings materially improve the reward-to-risk for a swing trade. This idea outlines an entry at $2…
First Watch (FWRG) sold off into a comfortable entry near $12.50 after a run of openings and strong top-line growth. Fundamentals show accelerating unit growth, healthy operating cash flow (~$130M annual), and a manageable balance sheet. The pullback is an opportunity: trade a mid-term long with clear entry, stop and target while watching same-rest…
Aveanna (AVAH) has turned in consistent revenue and EBITDA beats, raised 2026 guidance after the Family First buy, and is starting to meaningfully convert earnings into free cash flow while shrinking leverage. At a market cap near $2.9B and a P/E ~10.6, the shares look compelling for a long trade targeting further multiple expansion and earnings re…
TKNZ operates core infrastructure for tokenized securities issuance, custody and settlement. With a $4.2 billion market cap, a growing issuer pipeline and regulatory headway in several jurisdictions, the company looks set to convert early partnerships into recurring, high-margin ARR. This trade idea lays out an actionable long with entry at $42.00,…
RB Global has seen a sharp, sentiment-driven pullback that looks overdone relative to the company's operational footing. We see a clear setup for a swing trade: enter on weakness, place a tight stop to limit downside, and scale out into the first target with room for a larger recovery if broader risk appetite returns.
Sylvamo (SLVM) sits near a cyclical low in free cash flow with a market cap of roughly $1.45B, a 4.9% dividend yield and modest multiples (P/E ~19, EV/EBITDA ~6.2). For patient swing traders, a long trade sized to a clear stop can capture upside as pricing, mix and working capital normalize over the next 45 trading days.
Hims & Hers (HIMS) has the topline growth and product expansion (GLP-1, testosterone, international) investors want, but the stock is trading with a large regulatory overhang. This trade targets a tactical long entry at $29.00 with a $38.00 target and a $25.50 stop, sized for a mid-term swing (45 trading days) to capture operational momentum while …
Meituan (MPNGY) looks set for a mid-horizon recovery after a Q2 sentiment shift. The ADR trades at ~$20 with a $61.8B market cap, a clean float and falling short interest. Technicals are mixed, but fundamentals - a dominant local services footprint and improving business mix - support a swing trade. Entry at $19.80, stop at $18.00, target $24.00 ov…
IREN's share price recently pulled back after an earnings miss, but the sell-off has outpaced the fundamental progress: large hyperscaler contracts, expanding capacity targets and a near-term revenue backlog argue for a recovery. This trade plan targets a swing to mid-term recovery while acknowledging execution and liquidity risks.
Figure Technology (FIGR) is executing on a blockchain-native capital marketplace playbook: rapidly growing consumer loan marketplace volume, healthy margins, and an accretive Kiavi acquisition. At $36.38, the risk/reward favors a medium-risk long aimed at capturing the next re-rating as partner productivity and tokenization scale revenue and free c…
Nvidia just reported blowout top-line momentum and laid out aggressive CPU revenue targets. The stock is trading at a PE of ~27.5 and a market cap near $5.35 trillion while the business is scaling to hundreds of billions in revenue and producing $127B of free cash flow. This trade buys the gap between corporate fundamentals and market price with a …
Innovex (INVX) is executing a distribution-led strategy that is lifting margins, cash flow and customer stickiness. With a $2.1B market cap, low leverage and $124m in free cash flow, the stock looks primed for a mid-term re-rating. This trade idea lays out an entry, stop and target with clear catalysts and risks.
Nvidia remains the dominant playbook for AI compute. This trade idea lays out a long entry at $700.00 with a $950.00 target and a $560.00 stop, arguing that secular AI and data-center secular demand justify keeping exposure while recognizing elevated valuation and execution risks.
VitalHub looks like a structurally better business than two years ago: recurring SaaS mix is higher, client retention has stabilized, and management is focused on margins. The stock, however, still trades at a deeply discounted multiple versus reasonable software comps. This trade targets that re-rating with a clear entry, stop and two-stage target…
NXGCF is an OTC microcap mining name showing improving technicals, rising short interest and heavy short-volume days. That mix creates an asymmetric trade: upside if momentum and any positive corporate/catalyst news triggers short covering, but downside if liquidity dries up or dilution appears. Enter at $1.06 with a stop at $0.85 and a mid-term ta…
Boeing's strategic move into Archer's orbit materially reduces execution risk and creates a clear path to commercialization for Archer's Midnight eVTOL. At a $4.43B market cap and $5.29 cash per share, Archer is still priced like a shot-in-the-dark. The Boeing deal compresses key risks and leaves a tradable setup: enter near $5.75, target $9.50 on …
Revolution Medicines (RVMD) just received FDA approval for RASONQUE (daraxonrasib) in metastatic pancreatic cancer and has secured a national specialty pharmacy partner for launch. The binary clinical risk has resolved and analysts model up to $11.5 billion in peak sales; the market cap of $44.6 billion already prices a lot of that optionality but …
BE Semiconductor (BESIY) builds the assembly equipment used for advanced packaging. As AI compute density drives adoption of hybrid bonding at scale, equipment demand and order cadence should accelerate. The stock is trading off recent highs near $374 and looks to be pricing a reset; this trade targets re-rating as hybrid bonding shortages become v…
Dick's Sporting Goods plunged after Q2 and weak Foot Locker metrics, but the selloff has pushed valuation to attractive levels: market cap ~$12.1B, P/E ~13.4, EV/EBITDA ~6.7 and a 3.6% yield. Technicals are oversold and an insider purchase shows conviction. Trade plan below for a mid-term rebound.
Fortrea is showing the kind of operating leverage investors want to see in a contract research organization: positive free cash flow ($196M last reported), improving book-to-bill (1.15x), and margin tailwinds driven by technology products like Fortrea Intelligent Technology. The stock is trading near $18.90 with technicals supportive and a favorabl…
Perpetua Resources is a development-stage play on the Stibnite Gold Project in Idaho that benefits from a $2.9 billion U.S. government loan commitment, attractive implied upside to historical highs, and improving technicals. The company remains pre-production with negative earnings and cash burn, so this is a conviction long trade sized for risk-to…
TransDigm’s pullback to $1,185 offers a chance to own a high-margin aerospace aftermarket platform that has consistent FCF and a clear acquisition runway. Valuation is elevated versus broad market multiples, but the company’s $2.74B quarterly revenue, $1.5B adjusted EBITDA and $2.436B free cash flow provide justification for a disciplined long-term…
Microsoft is the best-in-class AI infrastructure and software play that markets finally understand. Fundamentals - including $66.99B of free cash flow, 30% return on equity, and a conservative debt load - support continued multiple expansion as Azure AI wins enterprise wallets. Valuation is rich but reasonable given cash flow strength; this trade t…
Meta's stock is trading like its AI investments are a long-term drag. The numbers tell a different story: strong free cash flow, attractive ROE, and manageable leverage suggest the market is underpricing near-term monetization and optionality from AI and infrastructure deals. This trade targets a mid-term re-rate toward $700 with a $540 stop.
Phibro (PAHC) looks set to turn a recent acquisition into durable margin and cash-flow upside. The Zoetis medicated feed-additive portfolio and management continuity following a CEO transition create a clear operational catalyst. At a $1.53B market cap and EV/EBITDA of 8.95, the stock is reasonably valued for a company with improving revenue growth…
